Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
adenosine-5'-[beta, gamma-methylene]triphosphate
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
Adenosine‑5′‑[beta, gamma‑methylene]triphosphate is a synthetic nucleoside triphosphate analogue of ATP in which the oxygen atom bridging the beta and gamma phosphate groups is replaced by a methylene group. This modification renders it resistant to hydrolysis by most ATPases and phosphatases. It is widely used as an experimental tool in biochemical research to study ATP-dependent processes without rapid degradation. The compound can act as a substrate or inhibitor for various enzymes that normally use ATP and helps dissect mechanisms involving nucleotide binding and hydrolysis. Its primary utility is in laboratory settings rather than clinical applications[2][7].
- Other names
- Adenosine 5'-(Beta, Gamma-Methylene)TriphosphateADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATEadenosine (beta,gamma-methylene)triphosphateadenosine 5'-beta,gamma-methylenetriphosphateadenylyl methylene diphosphateadenylyl methylenediphosphateadenylyl(beta,gamma-methylene)diphosphonate3469–78–15'-adenylyl (beta,gamma-methylene)diphosphonate
02
Targets
RK (Ribokinase)
Beyond the preview
Go deeper on adenosine-5'-[beta, gamma-methylene]triphosphate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on adenosine-5'-[beta, gamma-methylene]triphosphate.